Senate Cuts Work Session Short; Part D Rebates Kick In; MedPAC To Focus On Implementing Drug Pricing Law

By John Wilkerson / October 3, 2022 at 2:14 PM

Congress has temporarily funded the government, and the Senate will skip the October work session, returning Nov. 14 with three work weeks to pass omnibus appropriations legislation that is supposed to be the vehicle for FDA policies left out of user fee reauthorization, and Medicare pay policies for doctors and hospitals.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.